Identification
Product identifiers, regulatory numbers, and supplier information
Product Information
- Product Name
- Lidocaine Hydrochloride Injection
- Synonyms
- Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-monohydrochloride; 2',6'-Acetoxylidide, 2-(diethylamino)-, hydrochloride
Regulatory Identifiers
- CAS Number
- N/A
Manufacturers & Suppliers
Hospira, Inc.
manufacturer
275 North Field Drive, Lake Forest, Illinois 60045, USA
224 212-2000
Emergency Contacts
CHEMTREC
800-424-9300
CHEMTREC
1-703-527-3887
CHEMTREC
61-290372994
CHEMTREC
44-870-8200418
Hazard Identification
GHS classification, signal word, pictograms, and hazard statements
Hazard Classifications
GHS Pictograms
GHS08
Hazard Statements
Precautionary Statements
Get a free compliance audit
Upload your SDS inventory and get a detailed compliance report
Composition / Information on Ingredients
Chemical components, concentration ranges, and hazardous substance identification
Non-hazardous ingredients include Water for Injection; some preparation may contain up to 7.5% dextrose. Hazardous ingredients present at less than 1% may include sodium chloride; sodium hydroxide and/or hydrochloric acid are used to adjust the pH. Multiple-dose vials contain 0.1% of methylparaben added as a preservative.
| Chemical Name | CAS Number | Concentration | Hazardous |
|---|---|---|---|
| Lidocaine Hydrochloride | 73-78-9 | 5% | Yes |
| Water for Injection | --- | --- | No |
| Dextrose | --- | 7.5% | No |
| Sodium Chloride | --- | 1% | Yes |
| Sodium Hydroxide | --- | --- | Yes |
| Hydrochloric Acid | --- | --- | Yes |
| Methylparaben | --- | 0.1% | Yes |
First Aid Measures
Emergency procedures for chemical exposure incidents
Remove from source of exposure. If signs of toxicity occur, seek medical attention. Provide symptomatic/supportive care as necessary.
Remove from source of exposure. Flush with copious amounts of water. If irritation persists or signs of toxicity occur, seek medical attention. Provide symptomatic/supportive care as necessary.
Remove from source of exposure. Flush with copious amounts of water. If irritation persists or signs of toxicity occur, seek medical attention. Provide symptomatic/supportive care as necessary.
Remove from source of exposure. If signs of toxicity occur, seek medical attention. Provide symptomatic/supportive care as necessary.
Immediate Medical Attention
If irritation persists or signs of toxicity occur, seek medical attention.
Medical Treatment
Provide symptomatic/supportive care as necessary.
Firefighting Measures
Extinguishing media, specific hazards, and firefighter protection
carbon dioxide, dry chemical extinguishing powder or foam
None anticipated from this aqueous product.
No special provisions required beyond normal firefighting equipment
Firefighter Protection
flame and chemical resistant clothing and self contained breathing apparatus
Accidental Release Measures
Spill cleanup procedures, containment, and environmental protection
Isolate area around spill.
Absorb any liquid with suitable material and clean affected area with soap and water.
Materials: suitable material, soap and water
Related Products
Similar products with comparable safety profiles
XYLOCAINE SOLUTION FOR ORAL PUMP SPRAY
CAS: Not applicable
CL-isopropanol
---
Clonidine (hydrochloride)
CAS: 4205-91-8
CHLORBENZOL / MDI MIX
---
L-Lysine hydrochloride
CAS: 657-27-2
Xylidine (mixture)
---
Doxorubicin (hydrochloride)
CAS: 25316-40-9
Aniline hydrochloride
CAS: 142-04-1
Handling and Storage
Safe handling precautions, storage conditions, and workplace requirements
No special handling required under conditions of normal product use.
No special storage required for hazard control. For product protection, follow storage recommendations noted on the product case label, the primary container label, or the product insert.
Exposure Controls / PPE
Occupational exposure limits, engineering controls, and protective equipment
Engineering controls are normally not needed during the normal use of this product.
If skin contact with the product formulation is likely, the use of latex or nitrile gloves is recommended.
Eye protection is normally not required during intended product use. However, if eye contact is likely to occur, the use of chemical safety goggles (as a minimum) is recommended.
Respiratory protection is normally not needed during intended product use. However, if the generation of aerosols is likely, and engineering controls are not considered adequate to control potential airborne exposures, the use of an approved air-purifying respirator with a HEPA cartridge (N95 or equivalent) is recommended under conditions where airborne aerosol concentrations are not expected to be excessive. For uncontrolled release events, or if exposure levels are not known, provide respirators that offer a high protection factor such as a powered air purifying respirator or supplied air. A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements must be followed whenever workplace conditions require respirator use. Personnel who wear respirators should be fit tested and approved for respirator use as required.
Physical and Chemical Properties
Appearance, physical state, melting point, boiling point, and material characteristics
Stability and Reactivity
Chemical stability, hazardous reactions, and incompatible materials
Stable under standard use and storage conditions.
Not determined.
Not determined. Hazardous polymerization: Not anticipated to occur with this product.
Not determined
Strongly alkaline conditions. Methyl vinyl ether; zinc.
Not determined. During thermal decomposition, it may be possible to generate irritating vapors and/or toxic fumes of carbon oxides (COx), nitrogen oxides (NOx), and hydrogen chloride.
Ecological Information
Environmental toxicity, biodegradation, and bioaccumulation data
The data for this section has not been processed yet.
Disposal Considerations
Waste treatment methods, disposal recommendations, and waste codes
All waste materials must be properly characterized. Further, disposal should be performed in accordance with the federal, state or local regulatory requirements.
Transport Information
UN numbers, shipping names, transport classes, and regulatory requirements
Regulatory Information
Chemical regulations, safety assessments, and compliance status
Medicinal products as defined in Directive 2001/83/EC are exempt from GHS/CLP and EU Dangerous Preparations Directive requirements in their finished state.
Frequently Asked Questions
Common questions about safety, handling, and properties
What other names is Lidocaine Hydrochloride Injection known by?
Lidocaine Hydrochloride Injection is also known as: Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-monohydrochloride; 2',6'-Acetoxylidide, 2-(diethylamino)-, hydrochloride
What is the hazard signal word for Lidocaine Hydrochloride Injection?
The signal word is warning.
What is the physical form of Lidocaine Hydrochloride Injection?
Lidocaine Hydrochloride Injection is a clear, colorless liquid appearing as clear, colorless liquid with colorless color.
What is the solubility of Lidocaine Hydrochloride Injection?
Very soluble in water and in alcohol; soluble in chloroform; insoluble in ether.
What are the hazard statements for Lidocaine Hydrochloride Injection?
This substance has 1 hazard statement:
- H373: May cause damage to organs through prolonged or repeated exposures